96 related articles for article (PubMed ID: 2659471)
1. [The pathogenic effect of human immunodeficiency virus. Molecular biological results].
Gürtler L; Hess F
Fortschr Med; 1989 Apr; 107(11):237-9. PubMed ID: 2659471
[TBL] [Abstract][Full Text] [Related]
2. [Etiology--characteristics of HIV infection].
Dierich MP; Larcher C; Sölder B; Schulz TF; Fuchs D; Wachter H
Wien Med Wochenschr; 1988 Oct; 138(19-20):482-6. PubMed ID: 3059685
[TBL] [Abstract][Full Text] [Related]
3. [Virulence of human immunodeficiency virus].
Brun-Vézinet F; Descamps D; Loussert-Ajaka I; Simon F
Rev Prat; 1995 Mar; 45(6):701-7. PubMed ID: 7754307
[TBL] [Abstract][Full Text] [Related]
4. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
[TBL] [Abstract][Full Text] [Related]
5. Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication.
Münch J; Schindler M; Wildum S; Rücker E; Bailer N; Knoop V; Novembre FJ; Kirchhoff F
J Virol; 2005 Aug; 79(16):10547-60. PubMed ID: 16051847
[TBL] [Abstract][Full Text] [Related]
6. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
Carl S; Greenough TC; Krumbiegel M; Greenberg M; Skowronski J; Sullivan JL; Kirchhoff F
J Virol; 2001 Apr; 75(8):3657-65. PubMed ID: 11264355
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus (HIV) from experimentally infected chimpanzees: isolation and characterization.
Castro BA; Walker CM; Tateno M; Cheng-Mayer C; Heberling R; Eichberg JW; Levy JA
J Med Primatol; 1989; 18(3-4):337-42. PubMed ID: 2760917
[TBL] [Abstract][Full Text] [Related]
8. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
9. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.
Ahmed RK; Norrgren H; da Silva Z; Blaxhult A; Fredriksson EL; Biberfeld G; Andersson S; Thorstensson R
Scand J Immunol; 2005 Jan; 61(1):63-71. PubMed ID: 15644124
[TBL] [Abstract][Full Text] [Related]
11. Effect of nef alleles on replication of human immunodeficiency virus type 1.
Zazopoulos E; Haseltine WA
Virology; 1993 May; 194(1):20-7. PubMed ID: 7683154
[TBL] [Abstract][Full Text] [Related]
12. Biologically diverse molecular variants within a single HIV-1 isolate.
Fisher AG; Ensoli B; Looney D; Rose A; Gallo RC; Saag MS; Shaw GM; Hahn BH; Wong-Staal F
Nature; 1988 Aug; 334(6181):444-7. PubMed ID: 2841608
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo.
Martin G; Tremblay MJ
Clin Immunol; 2004 Jun; 111(3):275-85. PubMed ID: 15183148
[TBL] [Abstract][Full Text] [Related]
14. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
[TBL] [Abstract][Full Text] [Related]
15. [Immunodeficiency viruses].
Ferreira WF; Pinto AS; Alvarez EP; Sousa RA
Acta Med Port; 1991 Dec; 4 Suppl 1():59S-63S. PubMed ID: 1805535
[TBL] [Abstract][Full Text] [Related]
16. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
[TBL] [Abstract][Full Text] [Related]
17. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
18. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
[TBL] [Abstract][Full Text] [Related]
19. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
20. Progression of HIV to AIDS: a protective role for HLA-B27?
den Uyl D; van der Horst-Bruinsma IE; van Agtmael M
AIDS Rev; 2004; 6(2):89-96. PubMed ID: 15332431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
